Randall Schatzman

Chief Executive Officer chez BOLT BIOTHERAPEUTICS, INC.

Fortune : 18 003 $ au 31/03/2024

69 ans

51 relations

Health Technology

Consumer Services

Commercial Services

Postes actifs de Randall Schatzman

Sociétés	Poste	Début	Fin
BOLT BIOTHERAPEUTICS, INC.	Director/Board Member	01/07/2019	-
BOLT BIOTHERAPEUTICS, INC.	Chief Executive Officer	01/07/2019	-
AlderBio Holdings LLC	Corporate Officer/Principal	-	-

Historique de carrière de Randall Schatzman

Anciens postes connus de Randall Schatzman

Sociétés	Poste	Début	Fin
ALDER BIOPHARMACEUTICALS, INC.	Director/Board Member	21/01/2013	20/03/2018
	Chief Executive Officer	01/01/2004	20/03/2018
	Founder	01/01/2004	20/03/2018
	Investor Relations Contact	01/01/2004	-
	President	01/01/2004	20/03/2018
Mercator Genetics, Inc. Mercator Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Progenitor, Inc., Mercator Genetics, Inc. develops gene therapy programs for asthma, schizophrenia, and cancer. The private company is based in Menlo Park, CA. Mercator Genetics was acquired by Progenitor, Inc. on February 18, 1997 for $22 million.	Corporate Officer/Principal	01/01/1995	01/01/1999
Vitaeris, Inc. Vitaeris, Inc. BiotechnologyHealth Technology Vitaeris, Inc. develops new treatment options for chronic inflammatory diseases. The company was founded by Kevin Chow, Patrick A. Robinson and Noel F. Hall in 2016 and is headquartered in Vancouver, Canada.	Director/Board Member	-	-
Syntex, Inc.	Corporate Officer/Principal	-	-
Celltech R&D, Inc. Celltech R&D, Inc. Drugstore ChainsRetail Trade Celltech R&D, Inc. provides research and development services for pharmaceutical products. The private company is based in Bothell, WA.	Corporate Officer/Principal	-	-

Formation de Randall Schatzman

Emory University	Doctorate Degree
Purdue University	Undergraduate Degree

Statistiques

Internationale

Etats-Unis	8
Canada	3

Opérationnelle

Corporate Officer/Principal	4
Director/Board Member	3
Chief Executive Officer	2

Sectorielle

Health Technology	4
Consumer Services	3
Commercial Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés liées

Sociétés cotées	1
BOLT BIOTHERAPEUTICS, INC.	Health Technology

Entreprise privées	6
Mercator Genetics, Inc. Mercator Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Progenitor, Inc., Mercator Genetics, Inc. develops gene therapy programs for asthma, schizophrenia, and cancer. The private company is based in Menlo Park, CA. Mercator Genetics was acquired by Progenitor, Inc. on February 18, 1997 for $22 million.	Commercial Services
Lundbeck Seattle BioPharmaceuticals, Inc. Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA.	Health Technology
Celltech R&D, Inc. Celltech R&D, Inc. Drugstore ChainsRetail Trade Celltech R&D, Inc. provides research and development services for pharmaceutical products. The private company is based in Bothell, WA.	Retail Trade
Syntex, Inc.	Miscellaneous
AlderBio Holdings LLC
Vitaeris, Inc. Vitaeris, Inc. BiotechnologyHealth Technology Vitaeris, Inc. develops new treatment options for chronic inflammatory diseases. The company was founded by Kevin Chow, Patrick A. Robinson and Noel F. Hall in 2016 and is headquartered in Vancouver, Canada.	Health Technology

Voir les connexions sociétés